This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.

 
Web www.patentalert.com

< Factor Xa compounds

> Methods and compositions employing a novel stearoyl-CoA desaturase-hSCD5

~ 00468